Organovo Holdings, Inc. (ONVO)

NASDAQ: ONVO · Delayed Price · USD
3.35
-0.39 (-10.43%)
At close: Jan 18, 2022 4:00 PM
3.48
0.13 (3.88%)
After-hours:Jan 18, 2022 6:39 PM EST
Market Cap29.16M
Revenue (ttm)n/a
Net Income (ttm)-11.14M
Shares Out8.71M
EPS (ttm)-1.40
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume91,146
Open3.73
Previous Close3.74
Day's Range3.31 - 3.77
52-Week Range3.32 - 23.92
Beta0.48
Analystsn/a
Price Targetn/a
Earnings DateNov 8, 2021

About ONVO

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug com...

IndustryBiotechnology
Founded2007
Employees11
Stock ExchangeNASDAQ
Ticker SymbolONVO
Full Company Profile

Financial Performance

Financial Statements

News

Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInk

SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today released its first detailed response to the lawsuit Cellink (NASDAQ Stockholm: BICO) filed against it in Delawa...

1 week ago - GlobeNewsWire

Organovo On Track to Establish Human 3D Disease Model in Inflammatory Bowel Disease in 2022

SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today provided a business overview and progress update, and announced it is on track to establish its first models of...

1 month ago - GlobeNewsWire

Organovo Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

SOLANA BEACH, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company's annual meeting of shareholders, on September 14, 2021, at 9:00 a.m. wa...

4 months ago - GlobeNewsWire

Catherine Wood's ARK Investment Slashes Organovo Holding

Catherine Wood ( Trades , Portfolio )'s ARK Investment Management has revealed a large reduction in the Organovo Holdings Inc. (NASDAQ:ONVO) position alongside a small reduction in the Syros Pharmaceuti...

Other symbols:SYRS
10 months ago - GuruFocus

Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONF...

SOLANA BEACH, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced it will be featured as a presenting company at the H.C. Wainwright Global Life Sciences C...

10 months ago - GlobeNewsWire

Organovo Regains Compliance with Nasdaq Minimum Bid Price Requirement

SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (“Organovo” or the “Company”) (Nasdaq: ONVO) announced today that it has regained compliance with the minimum bid price requiremen...

1 year ago - GlobeNewsWire

Organovo Announces One-for-Twenty Reverse Stock Split

SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (the “Company”) (Nasdaq: ONVO) today announced that it filed a certificate of second amendment to its certificate of incorporation ...

1 year ago - GlobeNewsWire

Will Organovo Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Organovo.

2 years ago - Zacks Investment Research

What Bargain Hunting ? Tap 5 Stocks With Rising P/E

Bet on these top-ranked stocks with rising P/E for outsized gains.

Other symbols:AVGRCYBRQLYS
2 years ago - Zacks Investment Research

Organovo (ONVO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Organovo (ONVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 years ago - Zacks Investment Research

Organovo Acknowledges Receipt of Proposal

Reiterates Commitment to Strategic Review Process Reiterates Commitment to Strategic Review Process

2 years ago - GlobeNewsWire

Organovo (ONVO) Reports Q1 Loss, Lags Revenue Estimates

Organovo (ONVO) delivered earnings and revenue surprises of 0.00% and -13.13%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

2 years ago - Zacks Investment Research

Organovo (ONVO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Organovo (ONVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 years ago - Zacks Investment Research

Options Traders Expect Huge Moves in Organovo (ONVO) Stock

Organovo (ONVO) needs investors to pay close attention to the stock based on moves in the options market lately.

2 years ago - Zacks Investment Research